Dr Reddy's Laboratories Ltd
NYSE:RDY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Dr Reddy's Laboratories Ltd
NYSE:RDY
|
IN |
|
C
|
China Reinsurance Group Corp
SWB:C53
|
CN |
|
ANTA Sports Products Ltd
F:AS7
|
CN |
|
Y
|
Yum! Brands Inc
F:TGR
|
US |
|
J
|
Jacobs Engineering Group Inc
F:JEG
|
US |
|
Nippon Television Holdings Inc
F:NP9
|
JP |
|
Tokyo Base Co Ltd
TSE:3415
|
JP |
|
K
|
Komatsu Ltd
XBER:KOM1
|
JP |
|
N
|
Newmont Corporation
TSX:NGT
|
US |
|
T
|
Trupanion Inc
SWB:TPW
|
US |
Wall St Price Targets
RDY Price Targets Summary
Dr Reddy's Laboratories Ltd
According to Wall Street analysts, the average 1-year price target for RDY is 14.16 USD with a low forecast of 10.88 USD and a high forecast of 19.03 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RDY's stock price target?
Price Target
14.16
USD
According to Wall Street analysts, the average 1-year price target for RDY is 14.16 USD with a low forecast of 10.88 USD and a high forecast of 19.03 USD.
What is the Revenue forecast for Dr Reddy's Laboratories Ltd?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Revenue has been 10%. The projected CAGR for the next 5 years is 7%.
What is the Operating Income forecast for Dr Reddy's Laboratories Ltd?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Operating Income has been 10%. The projected CAGR for the next 5 years is 6%.
What is the Net Income forecast for Dr Reddy's Laboratories Ltd?
Projected CAGR
2%
Over the last 13 years, the compound annual growth rate for Net Income has been 12%. The projected CAGR for the next 4 years is 2%.
